National Clinical Trials Database
Welcome to the eCancerTrials.com National Cancer Clinical Trials Database. When
you or a loved one are diagnosed with cancer, knowing every treatment option available
is your first step in receiving the most complete care. Your treatment plan may
include choosing to participate in a cancer clinical trial. Clinical trials in cancer
are research studies designed to evaluate new cancer treatment, management, and
prevention options. Clinical trials conducted with cancer patients evaluate the
safety and effectiveness of new or modified cancer treatment strategies. New anticancer
drugs, unique approaches to surgery and radiation therapy are used as well as various
combinations of cancer treatments.
Many medical professionals encourage those diagnosed with cancer to at least consider
participating in a clinical trial in addition to other treatment options. Furthermore,
many treatment options for cancer patients are only available through clinical trials,
making participation in a trial the only way to access certain therapies. So if
you are not evaluating potential cancer treatments accessible through the clinical
trials process alongside current standard therapies, you're not weighing all of
your available options.
Although there is currently no single, comprehensive source of available clinical
trials, eCancerTrials.com’s provides information on more than 2,000 clinical trials
being conducted by leading cancer researchers from all 50 states. These clinical
trials evaluate novel treatment approaches and new cancer drugs in all major cancer
types, including breast cancer, colon cancer, prostate cancer, lung cancer, lymphoma,
leukemia, and many others.
eCancerTrials.com is a free and confidential cancer clinical trials matching and
referral service. This resource is provided to cancer patients and their caregivers
by leading cancer information specialists at CancerConsultants.com. Interested patients
and their advocates may use this resource to:
- Search—free of charge—for clinical trials applicable to your situation.
- Search without sharing personal information until you find a trial that is appropriate.
At this point you can directly call or e-mail the cancer clinic or center conducting
the trial. In this manner your privacy is respected and ensured.
- eCancerTrials.com provides interested patients and their family members with additional services to help locate appropriate
clinical trials.
Use the search engine below to look for clinical trials, or
learn more about clinical trials.
Search by cancer type:
Displaying clinical trials in "Skin Cancer" in "All cancer stages" in "All States":
|
Protocol No. |
Title |
|
REFMAL30-SK |
A PHASE I, OPEN-LABEL, MULTI-DOSE, DOSE-ESCALATION STUDY OF GW572016 IN PATIENTS WITH SOLID TUMORS-SK
|
|
REFMAL39 |
A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Weekly for Three Consecutive Weeks of 28-Day Cycle in Patients with Solid Tumors
|
|
REFMAL31 |
A STUDY TO DETERMINE THE BIOEQUIVALENCE OF AN ORAL FORMULATION OF TOPOTECAN CONTAINING THE DRUG SUBSTANCE MANUFACTURED BY NEW PROCESS RELATIVE TO THE CURRENT STUDY FORMULATION OF TOPOTECAN IN PATIENTS WITH ADVANCED SOLID TUMORS
|
|
REFMAL32 |
AN OPEN-LABEL, SAFETY, PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF MULTIPLE DOSES OF GW572016 TO EXAMINE THE INHIBITION OF EGFR/ERBB-2 PHOSPHORYLATION IN CANCER PATIENTS WITH SOLID TUMORS
|
|
REFMAL33 |
A PHASE I TRIAL OF WEEKLY AMONAFIDE (AMF)IN PATIENTS WITH ADVANCED, SOLID TUMORS
|
|
REFMAL34 |
A PHASE I STUDY OF TOPOTECAN IN COMBINATION WITH DOCETAXEL IN PATIENTS WITH REFRACTORY AND/OR ADVANCED SOLID TUMORS
|
|
REFMAL29-Sk |
A PHASE I STUDY TO DETERMINE THE SAFETY AND PHARMACOKINETICS OF BMS-387032 GIVEN EVERY THREE WEEKS IN PATIENTS WITH METASTATIC REFRACTORY SOLID TUMORS-Sk
|